Assessment of the gait speed of elderly people with sarcopenia in the south of Minas Gerais
DOI:
https://doi.org/10.33448/rsd-v14i2.48368Keywords:
Sarcopenia; Elderly; Gait speed.Abstract
Introduction: Sarcopenia is a progressive and generalized musculoskeletal disorder, related to the reduction of muscle mass and functional capacity, in which gait speed is a means for assessing its severity. Objectives: To evaluate the gait speed of elderly sarcopenic patients and compare with results in the literature. Materials and methods: Study carried out at the orthopedics laboratory at Santa Casa de Alfenas and at the human performance laboratory at the physiotherapy clinic at the Federal University of Alfenas. Inclusion criteria: over 60 years old, SARC-F suggestive of sarcopenia and indicative handgrip test, without comorbidities. Sociodemographic, gait speed, and ethical procedures were evaluated. Results: 20 elderly people were selected, 30% obese, predominantly female; all had reduced gait speed. The sedentary, obese and with incomplete foundation presented lower gait speed. Discussion: The SARC-F questionnaire assesses the decline in muscle function, is easy to measure and mainly detects severe cases, with low sensitivity and high specificity. The handgrip test assesses muscle strength, indicating sarcopenia at values below the reference. Together, they indicate sarcopenia and are sufficient for intervention in clinical practice, however, the given study suggests the assessment of complementary gait speed, due to its easy measurement, ability to assess the physical performance of the elderly and predisposition to functional decline. Conclusion: All those included in the study demonstrated reduced gait efficiency. The groups with overweight, sedentary and incomplete fundamentals adopted a lower gait speed.
References
Abellan Van Kan, G., Rolland, Y., Andrieu, S., Bauer, J., Beauchet, O., Bonnefoy, M., et al. (2009). Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people: an International Academy on Nutrition and Aging (IANA) Task Force. Journal of Nutrition, Health & Aging, 13(10), 881-889.
Barbosa-Silva, T. G., et al. (2016). Enhancing SARC-F: improving sarcopenia screening in the clinical practice. Journal of the American Medical Directors Association, 17(12), 1136-1141.
Binotto, M. A., Lenardt, M. H., & Rodríguez-Martínez, M. D. C. (2018). Physical frailty and gait speed in community elderly: a systematic review. Revista da Escola de Enfermagem da USP, 52, e03392.
Cannataro, R., et al. (2021). Sarcopenia: etiology, nutritional approaches, and miRNAs. International Journal of Molecular Sciences, 22(18), 9724.
Costa, T. B., & Neri, A. L. (2011). Medidas de atividade física e fragilidade em idosos: dados do fibra campinas, São Paulo, Brasil. Cadernos de Saúde Pública, 27(8), 1537-1550.
Cristaldo, M. R. A., et al. (2021). Rastreamento do risco de sarcopenia em adultos com 50 anos ou mais hospitalizados. Revista Brasileira de Geriatria e Gerontologia, 24(2).
Cruz-Jentoft, A. J., & Sayer, A. A. (2019). Sarcopenia (vol 393, pg 2636, 2019). Lancet, 393(10191), 2590-2590.
Cruz-Jentoft, A. J., et al. (2010). Sarcopenia: European consensus on definition and diagnosis. Report of the European Working Group on Sarcopenia in Older People. Age and Ageing, 39(4), 412-423.
Cruz-Jentoft, A. J., et al. (2019). Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing, 48(1), 16-31.
Dhillon, R. J. S., & Hasni, S. (2017). Pathogenesis and management of sarcopenia. Clinics in Geriatric Medicine, 33(1), 17-26.
Faria, Â., et al. (2021). Desenvolvimento das versões portuguesas dos questionários FRAIL Scale e SARC-F: ferramentas de rastreio para a fragilidade física e sarcopenia. Acta Portuguesa de Nutrição, 90-94.
Guedes, R. C., Dias, R. C., Neri, A. L., Ferriolli, E., Lourenço, R. A., & Lustosa, L. P. (2019). Declínio da velocidade da marcha e desfechos de saúde em idosos: dados da rede fibra. Fisioterapia e Pesquisa, 26(3), 304-310.
Harvey, N. C., Odén, A., Orwoll, E., et al. (2018). Medidas de desempenho físico e força muscular como preditores de risco de fratura independente de FRAX, quedas e aBMD: uma meta-análise do estudo de fraturas osteoporóticas em homens (MrOS). J Bone Miner Res, 33, 2150.
Kitamura, A., et al. (2021). Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults. Journal of Cachexia, Sarcopenia and Muscle, 12(1), 30-38.
Luukinen, H., Koski, K., Laippala, P., & Kivelä, S. L. (1995). Preditores de quedas recorrentes em idosos domiciliares. Scand Journal Prim Health Care, 13, 294.
Maggio, M., et al. (2016). Instrumental and non-instrumental evaluation of 4-meter walking speed in older individuals. PloS One, 11(4), e0153583.
Malmstrom, T. K., et al. (2016). SARC‐F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. Journal of Cachexia, Sarcopenia and Muscle, 7(1), 28-36.
Mehmet, H., Robinson, S. R., & Yang, A. W. H. (2020). Assessment of gait speed in older adults. Journal of Geriatric Physical Therapy, 43(1), 42-52.
Mijnarends, D. M., Luiking, Y. C., Halfens, R. J. G., et al. (2018). Músculo, saúde e custos: um olhar sobre sua relação. J Nutr Saúde Envelhecimento, 22, 766–773.
Nishikawa, H., et al. (2021). Screening tools for sarcopenia. In Vivo, 35(6), 3001-3009.
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria/RS. Ed. UAB/NTE/UFSM
Riuzzi, F., et al. (2018). Cellular and molecular mechanisms of sarcopenia: the S100B perspective. Journal of Cachexia, Sarcopenia and Muscle, 9(7), 1255-1268.
Shitsuka, R. et al. (2014). Matemática fundamental para tecnologia. 2ed. Editora Erica
Silva Alexandre, T., De Oliveira Duarte, Y. A., Ferreira Santos, J. L., Wong, R., & Lebrão, M. L. (2014). Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus Dynapenia as a risk factor for disability in the elderly. The Journal of Nutrition, Health and Aging, 18(5), 547-553.
Stenholm, S., Harris, T. B., Rantanen, T., et al. (2008). Sarcopenic obesity-definition, etiology and consequences. Curr Opin Clin Nutr Metab Care, 11(6), 693-700.
Studenski, S., Perera, S., Patel, K., et al. (2011). Velocidade de marcha e sobrevivência em idosos. JAMA, 305, 50.
Tournadre, A., et al. (2019). Sarcopenia. Joint Bone Spine, 86(3), 309-314.
Woo, J., Leung, J., & Morley, J. E. (2014). Validating the SARC-F: a suitable community screening tool for sarcopenia? Journal of the American Medical Directors Association, 15(9), 630-634.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Arthur Henriques Silva; Gabriel Libério Rocha Gomes; Bárbara Bianca Melo Toledo; Mateus Elias Sant’Anna Ferreira Ribeiro; Eli Ávila de Souza Junior
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
